文献速递咽喉与嗓音

喉咽反流病治疗的最小有效疗程:一项前瞻性研究

Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-07-04

这项前瞻性非对照研究纳入159例原发性喉咽反流病患者,在24小时下咽-食管多通道腔内阻抗-pH监测后接受质子泵抑制剂、藻酸盐或镁铝加合物治疗,用反流症状评分在基线及治疗后1、3、6、9个月评估症状。治疗后1个月61.0%为早期应答者,32.7%患者停药;62例早期无应答者中34例(21.4%)在3至9个月后应答,累计治疗成功率从1个月的61.0%升至9个月的82.4%至99.3%。

要点

  • 治疗后1个月61.0%患者为早期应答者,32.7%患者此时停药。
  • 62例早期无应答者中34例(21.4%)在3至9个月治疗后才应答。
  • 累计治疗成功率从1个月61.0%升至9个月82.4%至99.3%。

核心结论

  • 1个月治疗方案可能足以治疗三分之一的喉咽反流病患者,早期无应答者可能需要3至9个月治疗。

研究设计与样本

  • 前瞻性非对照研究,在大学医学中心招募经24小时下咽-食管多通道腔内阻抗-pH监测诊断的喉咽反流病患者。
  • 共159例患者完成研究,平均年龄49.9±15.7岁。
  • 根据喉咽反流病类型,患者接受质子泵抑制剂、藻酸盐或镁铝加合物联合治疗。
  • 在基线及治疗后1、3、6、9个月用反流症状评分评估症状,用反流体征评估量表评估体征。

主要发现

  • 治疗后1个月97例(61.0%)为早期应答者,52例(32.7%)停止治疗。
  • 62例早期无应答者中34例(21.4%)在3至9个月后达到应答。
  • 累计治疗成功率从治疗后1个月61.0%逐步升高至9个月82.4%至99.3%。
  • 早期应答者的反流症状评分主要在治疗第1个月下降,早期无应答者的反流症状评分在9个月治疗期间逐步下降。
  • 基线反流症状评分严重程度是治疗应答的强预测因素。

关键数值与推荐

  • 治疗后1个月早期应答者97例(61.0%),停药52例(32.7%)。
  • 早期无应答者62例,其中34例(21.4%)在3至9个月后应答。
  • 累计治疗成功率1个月61.0%,9个月82.4%至99.3%。

临床怎么用

  • 作者认为1个月治疗方案可能足以治疗三分之一的喉咽反流病患者。
  • 作者认为早期无应答者可能需要3至9个月治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the minimum therapeutic duration for patients with primary laryngopharyngeal reflux disease (LPRD) through the evaluation of symptom changes at multiple time points. STUDY DESIGN: Prospective uncontrolled. SETTING: University medical center. METHODS: Patients with LPRD at the 24-hour hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring were recruited from the European Reflux Clinic. Depending on the type of LPRD, patients were treated with a combination of proton-pump inhibitors, alginate, or magaldrate. Symptoms were evaluated with the reflux symptom score (RSS) at baseline and throughout treatment (1-, 3-, 6-, and 9-month posttreatment). The most appropriate therapeutic duration was determined using the RSS changes. Signs were evaluated with the reflux sign assessment. RESULTS: A total of 159 patients completed the study. The mean age was 49.9 ± 15.7 years. At 1-month posttreatment, 97 patients (61.0%) were considered as early responders to treatment, and the treatment was stopped for 52 patients (32.7%). Of the 62 early nonresponders, 34 patients (21.4%) reached responded to treatment after 3 to 9 months. The cumulative therapeutic success rate at 1-month posttreatment (61.0%) progressively increased to reach a range of 82.4% to 99.3% at 9-month posttreatment. The RSS mainly decreased in the first month of treatment in early responders. In early nonresponders, RSS progressively decreased throughout the 9-month treatment period. The baseline severity of RSS is a strong predictor of therapeutic response. CONCLUSION: A therapeutic regimen of 1 month can be sufficient to treat one third of LPRD patients. The early nonresponders may require 3 to 9 months of treatment.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lechien JR. Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study. Otolaryngol Head Neck Surg. 2024. PMID: 38961817. doi:10.1002/ohn.878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。